high secondary antibody responses were observed in immunized animals previously inoculated with a sub-immunogenic dose of hbsag indicating that hepatitis b iscoms may represent a suitable immunogen for use in individuals in whom a course of immunization with currently licensed hepatitis b vaccines has failed to produce a significant anti-hbs response .
C0019168
hbsag
C0019163
hepatitis b